New Article
The Advent of Patient-Centric Technologies to Combat the High Dropout Rates: Revolutionizing Clinical
Trials
With medical research dropout rates in clinical trials often exceeding 30%, impacting therapeutic development, investment, time, and structure of protocols, is there a better path to novel discoveries?
The author advocates for a paradigm shift towards patient-centric clinical trials that prioritize the participant experience to enhance retention and diversity
of study populations using digital platforms and artificial intelligence.
These technologies improve remote accessibility, mitigate financial barriers, streamline patient recruitment, and improve data capture. The ultimate goal is to make clinical trials more accessible and inclusive, yielding results that are representative of the broader population.
To learn more, visit
DOI: https://doi.org/10.30953/thmt.v9.474
Author
Harsha K. Rajasimha, PhD | Founder and CEO, Jeeva Clinical Trials, Manassas, Virginia,
USA
For more articles bridging research excellence with real world implementation and impact, see https://telehealthandmedicinetoday.com/index.php/journal/index